{"id":"adapalene-lotion-0-1","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Skin irritation"},{"rate":"5-10%","effect":"Dryness"},{"rate":"5-10%","effect":"Redness"}]},"_chembl":{"chemblId":"CHEMBL1265","moleculeType":"Small molecule","molecularWeight":"412.53"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This leads to increased cell turnover, reduced comedogenesis, and improved skin appearance. Adapalene's mechanism is similar to other retinoids, but its unique formulation allows for better penetration and reduced irritation.","oneSentence":"Adapalene is a topical retinoid that works by binding to retinoic acid receptors, modulating gene expression and promoting cell turnover.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:59:38.335Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acne vulgaris"},{"name":"Aging skin"}]},"trialDetails":[{"nctId":"NCT01046565","phase":"PHASE1","title":"Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2010-01","conditions":"Skin Manifestations","enrollment":75},{"nctId":"NCT01046396","phase":"PHASE1","title":"Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2010-01","conditions":"Skin Manifestations","enrollment":69},{"nctId":"NCT00599521","phase":"PHASE3","title":"Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2007-11","conditions":"Acne Vulgaris","enrollment":1067},{"nctId":"NCT00883233","phase":"PHASE3","title":"Comparison of Four Different Regimens of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2009-04","conditions":"Acne","enrollment":123},{"nctId":"NCT00598832","phase":"PHASE3","title":"Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2007-11","conditions":"Acne Vulgaris","enrollment":1075},{"nctId":"NCT00971282","phase":"PHASE4","title":"Adjunctive Usage of a Moisturizing Lotion (Cetaphil® Moisturizing Lotion) to Limit the Skin Irritation Linked to the Set-Up of a Treatment by Topical Retinoid (Differin® Gel 0,1%) in Healthy Subjects of Chinese Origins","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2008-12","conditions":"Healthy Skin","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":13,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Differin Lotion 0.1%","Differin® Lotion 0.1%"],"phase":"phase_3","status":"active","brandName":"adapalene lotion 0.1%","genericName":"adapalene lotion 0.1%","companyName":"Galderma R&D","companyId":"galderma-r-d","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Adapalene is a topical retinoid that works by binding to retinoic acid receptors, modulating gene expression and promoting cell turnover. Used for Acne vulgaris, Aging skin.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}